Get started
BADQOMOCAWGOWLD

$BPTH Bio-Path Holdings Inc (% of Vol Shorted- Mar 11: 60.93%)

Long
Bio-Path Holdings, Inc. (BATS:BPTH)  
BADQOMOCAWGOWLD  
BATS:BPTH   Bio-Path Holdings, Inc.
Trend Analysis Harmonic Patterns Chart Patterns Contains IO script
1
0
trendanalysis harmonicpatterns chartpattern containsioscript
BPTH Bio-Path Holdings Inc (% of Vol Shorted- Mar 11: 60.93%)
Sky High!!!
Target PTs 486 - 1,236 and higher

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.